menu
    • menu

    Company profile for NovalGen

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond.Headquartered in Lon...
    NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond.Headquartered in London, UK, NovalGen was formed in 2019. The company is based on proprietary innovations from UCL, London UK.NovalGen has been growing into a world-class, cutting edge, Immuno-oncology company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovalGenunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Argyle House Joel Street Northwood Hills HA6 1NW
    Telephone
    Telephone
    +44(0207) 139 8639
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.novalgen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novalgen/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NovalGen Initiates First Self-Regulating Immunotherapy Trial
    NovalGen Initiates First Self-Regulating Immunotherapy Trial

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151665/0/en/NovalGen-to-Begin-World-s-First-Clinical-Trial-for-a-Self-Regulating-Immunotherapy.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    Mabion, NovalGen Partner to Bring NVG-222 to Market
    Mabion, NovalGen Partner to Bring NVG-222 to Market

    30 Jun 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/mabion-novalgen-partner-to-bring-nvg-222-to-market/

    CONTRACTPHARMA
    30 Jun 2025
    Share Share
    NovalGen announces one oral and one poster presentation at Annual Meeting
    NovalGen announces one oral and one poster presentation at Annual Meeting

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2772743/0/en/NovalGen-announces-one-oral-and-one-poster-presentation-at-the-65th-American-Society-of-Hematology-Annual-Meeting.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    NovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors
    NovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors

    09 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/09/2585043/0/en/NovalGen-appoints-Dr-Michael-Owen-and-Mr-Scott-Clark-to-the-Board-of-Directors.html

    GLOBENEWSWIRE
    09 Jan 2023
    Share Share
    NovalGen announces one oral and two poster presentations at the ASHAM
    NovalGen announces one oral and two poster presentations at the ASHAM

    03 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/03/2547911/0/en/NovalGen-announces-one-oral-and-two-poster-presentations-at-the-American-Society-of-Hematology-Annual-Meeting.html

    GLOBENEWSWIRE
    03 Nov 2022
    Share Share
    NovalGen announces compelling data from the PI/II Study of NVG-111
    NovalGen announces compelling data from the PI/II Study of NVG-111

    26 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/26/2451694/0/en/NovalGen-announces-compelling-data-from-the-Phase-1-2-Study-of-NVG-111-at-the-ASCO-Annual-Meeting.html

    GLOBENEWSWIRE
    26 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search